Johnson and Johnson wins baby powder-cancer litigation case in US Medical Dialogues Bureau23 Dec 2019 12:43 PM ISTThe litigation case (Forrest) in St Louis, Missouri in the US has resulted in a verdict for Johnson & Johnson (JnJ), finding Johnson's baby powder...
Glenmark recalls Ranitidine in US over potential presence of cancer-causing NDMA Medical Dialogues Bureau23 Dec 2019 10:00 AM IST"Glenmark will continue to fully cooperate with the FDA as the agency evaluates ranitidine products for the presence of NDMA (a substance that could...
Lupin to provide access to latest developments in field of gastroenterology in India Medical Dialogues Bureau23 Dec 2019 9:45 AM ISTThrough this initiative, Lupin aims to bring in global educational material and provide access to the latest developments in the field of...
GSK fails to secure USFDA nod for HIV injection Cabenuva Medical Dialogues Bureau23 Dec 2019 9:40 AM ISTThe unit of GSK, which is challenging HIV drug market leader Gilead Sciences, said it will work with the FDA to determine the next steps for the new...
IceCure cryoablation technology gets USFDA nod to treat tumours in liver, kidney Medical Dialogues Bureau23 Dec 2019 9:00 AM ISTIt has focused on breast tumours, but now the U.S. Food and Drug Administration (USFDA) approved new uses, such as against tumours in the kidney,...
NPPA fixes price of Cipla Synchrobreathe inhaler device; Details Medical Dialogues Bureau22 Dec 2019 2:26 PM ISTNew Delhi: Price of Synchrobreathe inhaler device manufactured by pharma giant Cipla has been set at Rs 67.20 after the National Pharmaceutical...
Ipca Labs, Medicines for Malaria Venture ink pact for antimalarial co-formulation Atoguanil Medical Dialogues Bureau22 Dec 2019 10:01 AM IST"Today, the manufacturing cost of atovaquone is believed to pose a barrier to the widespread use of atovaquone-proguanil based products in...
Lupin unveils generic equivalent of Hectorol Injection Medical Dialogues Bureau22 Dec 2019 9:40 AM ISTDoxercalciferol Injection, 4 mcg/2 mL (2 mcg/mL) Multi-dose Vials, is the therapeutic generic equivalent of Sanofi Genzyme’s Hectorol Injection, 4...
Cadila Healthcare Gujarat facility clears USFDA inspection Farhat Nasim22 Dec 2019 9:30 AM IST"We hereby inform that the USFDA inspected the Company’s topical manufacturing facility located in Ahmedabad from 16th to 20th December 2019," Cadila...
AstraZeneca-Daiichi breast cancer drug Enhertu gets speedy USFDA nod Medical Dialogues Bureau22 Dec 2019 9:17 AM ISTAstraZeneca- Daiichi's drug Enhertu, also known as DS-8201, targets HER2 protein, a major trigger of uncontrolled cell growth in about 20% cases of...
Novartis wins Medicaid nod for new sickle cell drug Adakveo in 2 US states Medical Dialogues Bureau22 Dec 2019 9:00 AM ISTIn November, the U.S. Food and Drug Administration approved Adakveo and Global Blood Therapeutic Inc's Oxbryta, which carries a list price of $125,000...
Glenmark to launch Ryaltris in Australia via partner Seqirus Medical Dialogues Bureau21 Dec 2019 12:07 PM ISTThis paves the way for the launch of Ryaltris in Australia through our partner, Seqirus. Australia will be the first market globally where Ryaltris...
